Announcements Trials
Browse Landscape

Phase

Phase 1 14Phase 2 6Phase NA 4Phase 3 3Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 11NETWORK 5INDUSTRY 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 1Non Squamous Lung Cancer 1Keratosis, Actinic 1

Interventions

Carboplatin 315Paclitaxel 303Cisplatin 250Docetaxel 238pembrolizumab 230Gemcitabine 214Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 121Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 93Prednisone 92Oxaliplatin 90atezolizumab 75Leucovorin 72durvalumab 69130-nm albumin-bound paclitaxel 68Injections 66Lenalidomide 63Irinotecan 62Bortezomib 56Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × Therapeutics × Clear all
NCT07137819 2025-08-22

EXACT-1

Aresus Pharma GmbH

Phase 3 Recruiting
280 enrolled
Dermatologic

Keratosis, Actinic

NCT00415246 2019-11-22

Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer

Ipsen

Phase 3 Terminated
100 enrolled
Genitourinary

Prostatic Neoplasms

NCT01154140 2017-11-06

PROFILE 1014

Pfizer

Phase 3 Completed
343 enrolled 31 charts
Thoracic

Non Squamous Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡